As evident from various clinical data, the decrease in the survival of colon cancer patients was highly correlated with the overexpression of molecules involved in cholesterol uptake (i.e., LDLR) and glucose metabolism, i.e., LDHA or MCT-4. Here, LDLR is linked to malignant colon neoplasm.